• Applicability of Turkish Pricing Policy on Price Increases

    Nov 1, 2014, 00:00
  • Economic Evaluation of Lanreotide Autogel in the Management of Acromegaly in Greece

    Nov 1, 2014, 00:00
  • Cost Effectiveness of Pentavalent Rotavirus Vaccine (Rv5) in Slovenia

    Nov 1, 2014, 00:00
  • The Impact of Economic Crisis on Suicide Rates in Greece

    Nov 1, 2014, 00:00
  • Drug Survival Rates And Cost of Biological Agents for the Treatment of Moderate to Severe Psoriasis in the Balearic Islands (Spain)

    Nov 1, 2014, 00:00
  • Effectiveness of Hand Hygiene Promotion in Relation to Level of Investment- A Systematic Review

    Nov 1, 2014, 00:00
  • The Inverse Correlation Between Internal And External Risk Under International Reference Pricing- An Analysis of Six European Countries

    Nov 1, 2014, 00:00
  • Comparing Three Different Methods of Half-Cycle Correction

    Nov 1, 2014, 00:00
  • Trends and Key Decision Drivers For Rejecting An Orphan Drug Submission Across Five Different HTA Agencies

    Nov 1, 2014, 00:00
  • Management of Ischaemic Stroke Patients Enrolled in the Japan Stroke Databank (JSD)

    Nov 1, 2014, 00:00
  • Median Hospitalization Cost and Length of Stay for Carbapenem-Resistant Verse Carbapenem-Sensitive Patients in a Tertiary Care Hospital in South India

    Nov 1, 2014, 00:00
  • Modeling Disease Progression In Alzheimer's Dementia To Inform HTA (CEA)

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Empagliflozin (Jardiance®) 10 Mg And 25 Mg Administered As An Add-On To Metformin And Sulfonilurea (Met+Su) Compared To Other Sodium-Glucose Co-Transporter 2 Inhibitors (Sglt2is) in Patients with Type 2 Diabetes Mellit ...

    Nov 1, 2014, 00:00
  • Budget Impact of Orphan Drugs In the Netherlands In The Period 2006-2012

    Nov 1, 2014, 00:00
  • Characteristics of Patients With Systemic Lupus Erythematosus (Sle) Currently On Remission, With Active Disease But Not Experiencing Flare, and Those Experiencing Flares In Clinical Practices In Europe

    Nov 1, 2014, 00:00
  • Adding Boceprevir Yields Better Cost-Saving for Chronic Hepatitis C Genotype 1 Treatment in Thailand

    Nov 1, 2014, 00:00
  • Joint Modelling Of The Change In Tumor Size And Overall Survival; A Parametric Model Considering Patient Heterogeneity Not Observed At Baseline

    Nov 1, 2014, 00:00
  • Patient Preferences in Treatment of Diabetes Mellitus- A Systematic Review of Stated Preference Surveys

    Nov 1, 2014, 00:00
  • Pricing Additional Benefit in Germany

    Nov 1, 2014, 00:00
  • A Critical Review of Chinese Pharmacoeconomics Studies in the Last Five Years

    Nov 1, 2014, 00:00
  • Clinical Trial-Based Cost-Effectiveness Analysis of Indacaterol (ONBREZ® 150 MCG) Versus Tiotropium (SPIRIVA®) in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) IN TURKEY

    Nov 1, 2014, 00:00
  • Pay-For-Performan Balancing Cost and Care

    Nov 1, 2014, 00:00
  • Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilisation Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy

    Nov 1, 2014, 00:00
  • The Importance and Use of Drug Utilization Review and Pharmacoeconomics

    Nov 1, 2014, 00:00
  • Opioid Prescribing and the Impact of Branded Generics

    Nov 1, 2014, 00:00
  • Impacts of Lower Back Pain- Refinement of the Pain Assessment for Lower Back-Impacts Questionnaire (Pal-I) Using a Mixed Methods Approach

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia In Portugal

    Nov 1, 2014, 00:00
  • Comparison of Disease Status and Outcomes of Patients With Ankylosing Spondylitis (As) Receiving Adalimumab Or Etanercept Monotherapy In Europe

    Nov 1, 2014, 00:00
  • Modelling Long-Term Changes In Opioid Induced Constipation (OIC)

    Nov 1, 2014, 00:00
  • Comparative Effectiveness of Biological Agents With Diseases Modifying Anti-Rheumatic Drugs For Methotrexate Failure Rheumatoid Arthritis Patients- A Baysian Mixed Treatment Comparison

    Nov 1, 2014, 00:00
  • Comparison of Disease Status And Outcomes of Patients With Rheumatoid Arthritis (Ra) Receiving Adalimumab or Etanercept Monotherapy In Europe

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Omalizumab in Chronic Idiopathic Urticaria Refractory to H1-Antihistamines in Turkey

    Nov 1, 2014, 00:00
  • Top 20 Orphan Drugs Availability, Pricing and Reimbursement In Slovakia- 2005-2012 Review

    Nov 1, 2014, 00:00
  • Economic Burden of Febrile Neutropenia in Solid Tumor and Lymphoma Patients- An Observational Study in Singapore

    Nov 1, 2014, 00:00
  • Development Of A Collaborative European Pharmacoepidemiologic Post-Authorization Safety Study (Pass) Programme Examining Rivaroxaban Use In Routine Clinical Practice

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of Bendamustin-Rituximab Compared to Chop-Rituximab in the Treatment of Indolent Follicular Non-Hodgkin Lymhoma in the Czech Republic

    Nov 1, 2014, 00:00
  • The Relevance of Health Services Research for the Pharmaceutical Industry in Germany –Results of A Representative Online Survey

    Nov 1, 2014, 00:00
  • PROF DR Hasbullah Thabrany

    Nov 1, 2014, 00:00
  • Pharmacoeconomic Study of Botulinium Toxin Type a in Treatment of Post-Stroke Spasticity in the Russian Federation- Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00
  • Analysing The Effects of a Disinvestment Decision in Breast Cancer Screening Programmes in Asia-Pacific Countries- A Modelling Approach

    Nov 1, 2014, 00:00
  • Evaluating Relationship Between White Blood Cells and Platelets During Recovery Phase In Dengue Hemorrhagic Fever Cases In Punjab, Pakistan- A Retrospective Study

    Nov 1, 2014, 00:00
  • Impact Of Pharmacoeconomic Guidelines on the Reimbursement Process of Medicines In Serbia In 2014

    Nov 1, 2014, 00:00
  • Cost Comparison Among First Line Monoclonal Antibodies-Based Oncology Treatment Protocols

    Nov 1, 2014, 00:00
  • Stratified Cost-Effectiveness Analysis To Guide Genetic Screening For Cancer Risk

    Nov 1, 2014, 00:00
  • Quality of Diabetes Care Among Obese and Overweight Patients at Nhg Polyclinics

    Nov 1, 2014, 00:00
  • Experiences With Price Competition of Biosimilar Drugs in Hungary

    Nov 1, 2014, 00:00
  • Efficacy Of Novel Dmards In Early Active Rheumatoid Arthritis- An Indirect Comparison

    Nov 1, 2014, 00:00
  • Cost Effectiveness Analysis of Flash Glucose Monitoring for Type 2 Diabetes Patients Receiving Insulin Treatment In The Uk

    Nov 1, 2014, 00:00
  • The Impact Of Daytime And Nocturnal Non-Severe Hypoglycaemic Events On People With Diabetes In Turkey

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Aprepitant in Egyptian Patients Receiving Highly Emetogenic Therapy from the Third Party Payer Perspective

    Nov 1, 2014, 00:00
  • The Pain Assessment for Lower Back Symptoms (Pal-S)- Refinement of A New Pro Instrument Through A Mixed Methods Approach

    Nov 1, 2014, 00:00
  • The Costs of Illness of Atopic Dermatitis in South Korea

    Nov 1, 2014, 00:00
  • Analyses on Temporal and Spatial Clustering and Changing Trend of HCV in Mainland of China

    Nov 1, 2014, 00:00
  • Budget Impect Analysis

    Nov 1, 2014, 00:00
  • Health Care Stakeholders' Evaluation of A User-Friendly Tool Which Estimates Long-Term Health Gains Following the Reduction of Ldl Levels

    Nov 1, 2014, 00:00
  • How Do Decision Makers in Europe Value Other Economic Evaluation Tools Than Cost-Effectiveness Analysis for Vaccines?

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of Ustekinumab Compared With Etanercept for the Treatment of Moderate to Severe Psoriasis in Costa Rica

    Nov 1, 2014, 00:00
  • Shared Decision-Making in Women with Early Stage Breast Cancer and Implications for Long-Term Health-Related Quality of Life

    Nov 1, 2014, 00:00
  • Functional Impairment and Cognitive Dysfunction in Depressed Patients in South-Korea- Results of Perform-K

    Nov 1, 2014, 00:00
  • Assessment Of The Impact Of Legislation On The Utilization Of Statins In Slovakia

    Nov 1, 2014, 00:00
  • Prevalence of Metabolic Syndrome in Patients with Schizophrenia According to the Presence or Absence of Negative Symptoms

    Nov 1, 2014, 00:00
  • Patterns and Predictors of Hospital Readmission in Taiwan

    Nov 1, 2014, 00:00
  • Development And External Validation Of A Risk Calculator For Predicting Anemia In Patients Treated With Triple Therapy (Tt) Containing Boceprevir (Boc), Pegylated Interferon And Ribavirin (Pr)

    Nov 1, 2014, 00:00
  • Assessment Of The Huntington Clinical Self-Reported Instrument (H-CSRI) Cross-Cultural Validity

    Nov 1, 2014, 00:00
  • Prescription of Rosiglitazone and Pioglitazone Folowing Safety Warnings- A Comparative Analysis of Trends in Dispensing Patterns in Denmark and Germany From 2007 To 2013

    Nov 1, 2014, 00:00
  • Markov Model-Based Economic Evaluation of Combination Therapy with Ezetimibe and Statin Monotherapy

    Nov 1, 2014, 00:00
  • A Chart Abstraction Based Method to Classify Real World Patients With Pulmonary Arterial Hypertension Based on Who Functional Classification

    Nov 1, 2014, 00:00
  • Cost Estimation Of Home Blood Pressure Monitoring Versus Combined Office And Ambulatory Measurements In Hypertension Management

    Nov 1, 2014, 00:00
  • Letting The Data Speak- A Shift of the Pharmaceutical Spending to Households in Greece

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Ranibizumab on Patients With Diffuse Diabetic Macular Edema Within the Public Mexican Health Care System

    Nov 1, 2014, 00:00
  • Bortezomib Re-treatment in Patients with Multiple Myeloma (MM). A Real World Medical Practice Experience from a Swedish National Registry

    Nov 1, 2014, 00:00
  • National Immunisation Technical Advisory Groups - A Framework For Assessment and Insights From Research

    Nov 1, 2014, 00:00
  • Acute And Chronic Impact Of Cardiovascular Events On Health State Utilities

    Nov 1, 2014, 00:00
  • Resources Utilization for the Investigation of Pulmonary Nodules in a University Hospital Center in Quebec, Canada

    Nov 1, 2014, 00:00
  • Preferences Regarding The Attributes Of Oral Anticoagulants In Patients With Atrial Fibrillation Results Of A Discrete Choice Experiment

    Nov 1, 2014, 00:00
  • Can A Global Value Dossier Meet Headquarters and Affiliates's Expectations?

    Nov 1, 2014, 00:00
  • Cost Effectiveness Of Renal Denervation Therapy For The Treatment Of Resistant Hypertension In The Netherlands

    Nov 1, 2014, 00:00
  • Quality of Life Decrements after Stroke

    Nov 1, 2014, 00:00
  • The Impact of the Income Per Capita in Chinese Family on Medical Expenditure

    Nov 1, 2014, 00:00
  • Comparability of Interview and Self-Administration of the Functional Assessment of Chronic Illness Therapy-Tuberculosis (Facit-Tb) Instrument in Iraqi Pulmonary Tuberculosis Patients

    Nov 1, 2014, 00:00
  • Price Comparison in the European Pharmaceutical Market

    Nov 1, 2014, 00:00
  • Assessment Of Diabetes Knowledge In Healthy Population Of Quetta City, Pakistan

    Nov 1, 2014, 00:00
  • Patients' Acceptance of Their Medication- Results From a French Multi-Diseases Study With Patient Online Community Using the Acceptance By the Patients of Their Treatment (Accept©) Questionnaire

    Nov 1, 2014, 00:00
  • Work Productivity Loss and Indirect Costs Associated with New Cardiovascular Events in High-Risk Patients with Hyperlipidemia - Estimates from Population-Based Register Data in Sweden

    Nov 1, 2014, 00:00
  • The Grass is Always Greener on the Other Side or Why There Is Little Meaning in International Pharmaceutical Price Comparison

    Nov 1, 2014, 00:00
  • Using the Analytic Hierarchy Process To Derive Health State Utilities From Ordinal Preference Data

    Nov 1, 2014, 00:00
  • Mapping May Cause Straining- The Inconsistent Relationship Between A Disease- Specific Questionnaire (Pac-Qol) And Eq-5d Mapping In Constipation

    Nov 1, 2014, 00:00
  • Evaluation of the Burden of Illness of u. S. Medicare Patients Diagnosed with Hyperpotassemia

    Nov 1, 2014, 00:00
  • Comparison of Epidemiology and Drug Treatment in HER2 Negative Metastatic Breast Cancer (MBC) in EU5

    Nov 1, 2014, 00:00
  • The Importance of Long-Term Surveillance of Stage IB Melanomas- Unexpectedly Low Survival Subsequent to Recurrence

    Nov 1, 2014, 00:00
  • Analysis of Factors Causing Chronic Obstructive Pulmonary Disease in Eastern Region of China

    Nov 1, 2014, 00:00
  • Clinical Trial Activity in Greece From 2010 To 2012- Still Missing the Opportunities?

    Nov 1, 2014, 00:00
  • Predictive Modeling to Assess Predictors of Treatment Success and Failure Among Combination Statin Therapy Patients

    Nov 1, 2014, 00:00
  • Economic Burden of Major Depressive Disorder (Mdd) in Five European Countries- Description of Resource use by Health State

    Nov 1, 2014, 00:00
  • A Prospective, Cross-Sectional Study On Cost And Adherence Of Antidiabetic Prescriptions At A Tertiary Care Teaching Hospital In South India

    Nov 1, 2014, 00:00
  • Systematic Review of Relapsed or Refractory Mantle Cell Lymphoma (MCL) Clinical Trials- Implications for Decision Modeling

    Nov 1, 2014, 00:00
  • Direct Non-Medical Costs Of Rheumatoid Arthritis By Disease Level In Portugal

    Nov 1, 2014, 00:00
  • What are the Key Driving Factors Behind RSA Decisions In Australia?

    Nov 1, 2014, 00:00
  • The Development and Preliminary Validation of the Manchester Early Morning Symptoms Index (Memsi) for People With Chronic Obstructive Pulmonary Disease (Copd)

    Nov 1, 2014, 00:00
  • Burden of Influenza B in 9 European Countries- A Literature Review

    Nov 1, 2014, 00:00
  • Validation of the Adherence Barriers Questionnaire (Abq) – An Instrument for Identifying Potential Risk Factors Associated With Medication-Related Non-Adherence

    Nov 1, 2014, 00:00
  • Impacts of Epro Data Collection Mode Selection on Patient Inclusion

    Nov 1, 2014, 00:00
  • An Italian Oncology Research to Evaluate Adherence to Clinical Guidelines for Cancer Treatment- The Right Program

    Nov 1, 2014, 00:00
  • Calculating Indirect Costs – Differences Caused by Various Approaches to Unit Costs. Results of Move to Work Study (M2W)

    Nov 1, 2014, 00:00
  • A Prospective Pharmacoeconomic Study of Bilateral Prostaglandin/ Prostamide Therapy for Lowering Intraocular Pressure (Iop) in the Patients in South India

    Nov 1, 2014, 00:00
  • Lipid Control After Percutaneous Coronary Intervention (PCI) in China

    Nov 1, 2014, 00:00
  • Economic Burden in Direct Costs of Chronic Obstructive Pulmonary Disease (COPD) in Russia

    Nov 1, 2014, 00:00
  • Fidaxomicin Therapy for Patients with Clostridium Difficile Infection- A Systematic Literature Review and Meta-Analysis

    Nov 1, 2014, 00:00
  • A Cost-Effectiveness Evaluation for a New Therapy in HIV Treatment

    Nov 1, 2014, 00:00
  • Supporting Interoperable Eu Patient Registries- Survey of Registry Holders' Needs

    Nov 1, 2014, 00:00
  • Determinants of Health Care Utilization in Hypertensive Patients- A Longitudinal Analysis

    Nov 1, 2014, 00:00
  • Joint Modeling of Primary and Secondary Non-Adherence Outcomes

    Nov 1, 2014, 00:00
  • Variations In Treatment Patterns and Disease Severity Among Patients With Psoriasis Receiving Their First Biologic Therapy In Europe (Eu)

    Nov 1, 2014, 00:00
  • Evidence-Based Medicine as a Driver of Improving Colorectal Cancer Screening in Ukraine

    Nov 1, 2014, 00:00
  • Awarness and Prevention of Chronic Diseases in Japan

    Nov 1, 2014, 00:00
  • Health Economic Evaluation of Guangdong Rural Tertiary Breast Cancer Screening and Diagnosis System

    Nov 1, 2014, 00:00
  • Overall Survival in Patients with HER2+ Early Stage Breast Cancer Patients Treated with Trastuzumab in the US Department of Defense Practice Setting

    Nov 1, 2014, 00:00
  • Health-Related Quality of Life in Italian Patients With Moderate and Severe Crohn's Disease- Interim Results from the Sole Study

    Nov 1, 2014, 00:00
  • Health Related Quality of Life And Health Care Utilization in Primary Care Patients With Moderate/Persistent Severity Asthma

    Nov 1, 2014, 00:00
  • Economic Evaluation Of Ferric Carboxymaltose In Patients With Chronic Heart Failure And Iron Deficiency- An Analysis For Greece Based On Fair-Hf Trial

    Nov 1, 2014, 00:00
  • Costed Treatment Pathways of Diffuse Large B Cell Lymphoma in a UK Population-Based Cohort- A Patient Level Simulation Model

    Nov 1, 2014, 00:00
  • Patient Specific Landscape of Information Technology Solutions for Diabetes Self-Management

    Nov 1, 2014, 00:00
  • Study On Drug Utilization And Assessment Of Stroke Risk Using Chads2 And Cha2ds2-Vasc Scoring In Elderly Patients With Non-Valvular Atrial Fibrillation

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis Of An Antimicrobial Transparent Dressing For Protecting Central Vascular Accesses In Critically Ill Patients Versus Standard Transparent Dressings In Fran A Comparison Of Two Modeling Approaches- Decision-Tree Ve ...

    Nov 1, 2014, 00:00
  • Nice's Proposed Value-Based Assessment of Health Technologies- Concerns of Inconsistent Consideration of Social Values

    Nov 1, 2014, 00:00
  • Market Access and Reimbursement- The Increasing Role of Real-World Evidence

    Nov 1, 2014, 00:00
  • Product Quality Aspect in Reimbursement of Medical Devices- Comparison of Turkey Verse Europe

    Nov 1, 2014, 00:00
  • Efficacy of Treatments for Macular Oedema Secondary to Branch Retinal Vein Occlusion- A Network Meta-Analysis

    Nov 1, 2014, 00:00
  • The Incidence, Prevalence, and Survival of Malignant Melanoma in Taiwan

    Nov 1, 2014, 00:00
  • Mapping from SF-6D to EQ-5D- Changes in Estimates Based on the Choice of Algorithm

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of Interventions Aimed at Decreasing The Number of Amputations Among Patients With Diabetes Mellitus

    Nov 1, 2014, 00:00
  • Change in Percentage of Left Ventricular Ejection Fraction in Breast Cancer Patients Received Trastuzumab Treatment

    Nov 1, 2014, 00:00
  • Inadequate Pain Relief Among Patients With Primary Knee Osteoarthritis - Analysis From The Portuguese Sample Of The Survey Of Osteoarthritis Real World Therapies (Sort)

    Nov 1, 2014, 00:00
  • Will Nurses Have Better Outcomes than Non-Medical Working Women when Hospitalized for Female Genital Diseases?

    Nov 1, 2014, 00:00
  • How Does Non-Malignant Opioid Induced Constipation (Oic) Impact Health State Utility?

    Nov 1, 2014, 00:00
  • Economic Evaluation of Nalmefene for the Treatment of Alcohol Dependence in Greece

    Nov 1, 2014, 00:00
  • Assessment of Rural Health Purchasing Arrangements In China

    Nov 1, 2014, 00:00
  • The Impact of Cost Containment Reforms to the Pharmaceutical Benefits Scheme (Pbs) On Prescribing Volumes And Expenditure In Australia- 1992 To 2011

    Nov 1, 2014, 00:00
  • Are Patient Reported Outcomes Relevant To Patients? Learnings From A Patient Advocate Survey

    Nov 1, 2014, 00:00
  • Assessment of the Methodological Quality of Randomized Controlled Trials Published in "Russian Allergology Journal" in 2009-2013

    Nov 1, 2014, 00:00
  • Clinical Outcome Assessment (Coa) Instrument Scoring- the Validity and Precision of Unweighted Summary Scores Verse Irt Weighted Scores, and the Added Value of Irt Standard Errors

    Nov 1, 2014, 00:00
  • The Efficiency Evaluation of the Rule From Drug Market Regulation Chamber (Cmed) Proposed To Public Medicines Acquisitions

    Nov 1, 2014, 00:00
  • Clinical and Economic Analysis of Effectiveness of Everolimus in the Treatment Of HR+, HER2- Advanced Breast Cancer in Russia

    Nov 1, 2014, 00:00
  • Resource Use and Health Care Costs of Chronic Obstructive Pulmonary Disease in Slovakia

    Nov 1, 2014, 00:00
  • WX-III-287-19 A Possible Thromboxane Antagonist in Bovine Coronary Arteries

    Nov 1, 2014, 00:00
  • Design Methods For Study Of Prevalence, Risk Factors And Economic Burden Of Insulin Injection-Related Lipohypertrophy In China

    Nov 1, 2014, 00:00
  • Ten Years Outcomes in a Cohort of Patients Started on Antiretroviral Treatment in an Urban Clinic in Sub-Saharan Africa

    Nov 1, 2014, 00:00
  • In-Patient Hospital Costs of Stroke- A Focused Literature Review

    Nov 1, 2014, 00:00
  • Initial Inappropriate Antibiotic Therapy in Hospitalized Patients with Gram-Negative Infections- Systematic Review And Meta-Analysis

    Nov 1, 2014, 00:00
  • Early Cost-Effectiveness Modeling for Tumor Infiltrating Lymphocytes (TIL) -Treatment Versus Ipilimumab in Metastatic Melanoma Patients

    Nov 1, 2014, 00:00
  • Should Cost-Effectiveness Analysis Include The Cost Of Consumption Activities? An Empirical Investigation

    Nov 1, 2014, 00:00
  • Work Productivity Loss Due To Rheumatoid Arthtiris (Ra), Crohn's Disease (Cd) And Psoriasis (Ps) In Poland

    Nov 1, 2014, 00:00
  • The Selection of Appropriate Health State Utility Values (Hsuvs) for Health Technology Assessment (Hta)- Lessons To Be Learnt

    Nov 1, 2014, 00:00
  • Implementation of Technologies Based on the Evidence-Based Medicine and Hta in the Management of Hepatitis C

    Nov 1, 2014, 00:00
  • Drug Access Is Improved By The Essential Drug System And “Low-Priced Drug” Policy In China

    Nov 1, 2014, 00:00
  • Payer's Perceptions of Glucagon Kits Aimed at Reducing Administration Complexity During Severe Hypoglycemic Events

    Nov 1, 2014, 00:00
  • The Cost-Effectiveness Analysis of Two Pegylated Interferon ALFA Treatment for Chronic HCV Infection in China

    Nov 1, 2014, 00:00
  • Hearing the Patient's Voice in Health Care- A Survey Analysis of Patients' Perceptions of Difficulties in Shared Clinical Decision-Making

    Nov 1, 2014, 00:00
  • Impact of Economic Crisis on the Greek Health Care System and on the Population Health

    Nov 1, 2014, 00:00
  • Economic Impact of Using Subcutaneous Trastuzumab

    Nov 1, 2014, 00:00
  • Assesing the Impact of Patent Loss on Overall Revenues and Stocks Price of Pharmaceutical Companies

    Nov 1, 2014, 00:00
  • Use Of External Data To Guide Long-Term Survival Extrapolations Of Trial Data For Chronic Lymphocytic Leukemia

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of the Treatment of Respiratory Diseases of Xiyanping Injection - A Systematic Review

    Nov 1, 2014, 00:00
  • Clinical Trials in Fran An Underexploited Opportunity

    Nov 1, 2014, 00:00
  • Validity of the Eq-5d-5l in Stroke Patients

    Nov 1, 2014, 00:00
  • Cognitive Function And Non-Adherence To Antihypertensive Medications

    Nov 1, 2014, 00:00
  • What is the Most Cost-Effective Strategy for Treating Chronic Myeloid Leukemia After Imatinib Loses Patent Exclusivity in Europe?

    Nov 1, 2014, 00:00
  • Systematic Review of Observational Studies and Rcts of Omalizumab in Severe Persistent Allergic Asthma and Meta-Analysis Feasibility Assessment

    Nov 1, 2014, 00:00
  • Cost-Effectiveness of A Short Message Service (Sms) Intervention To Prevent Type 2 Diabetes Among Adults With Impaired Glucose Tolerance

    Nov 1, 2014, 00:00
  • Development of a Survey to Quantify Parents' Priorities for Vaccinating Children Against Rotavirus

    Nov 1, 2014, 00:00
  • Economic Impact of Combining Metformin with Dipeptidyl Peptidase Inhibitors In Diabetic Patients With Renal Failure

    Nov 1, 2014, 00:00
  • Modelling Longitudinal Trajectories of Patient-Reported Outcomes To Evaluate Treatment Effect

    Nov 1, 2014, 00:00
  • Provincial Entry of New Drugs In China

    Nov 1, 2014, 00:00
  • The Prevalence and Disease Burden of Treatment-Resistant Depression - a Systematic Review of the Literature

    Nov 1, 2014, 00:00
  • Cost-Minimization Analysis of Methadona Opioid Analgesic for Mexican Patients With Acute and Chronic Secondary Cancer As Rotation Option In Severe Pain

    Nov 1, 2014, 00:00
  • Comparative Cost-Effectiveness of CT Perfusion for Selecting Stroke Patients for Thrombolysis

    Nov 1, 2014, 00:00
  • What Really Matters? A Multi-View Perspective of One Patient's Hospital Experience

    Nov 1, 2014, 00:00
  • Impact of Health Care Reform on Drug Reimbursement Decision-Making In Taiwan

    Nov 1, 2014, 00:00
  • An Evaluation of Medical Resource Utilisation In Patients With Autosomal Dominant Polycystic Kidney Disease In Europe

    Nov 1, 2014, 00:00
  • Availability of Risk Sharing Agreements in the Turkish Pharmaceutical Sector

    Nov 1, 2014, 00:00
  • Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regionally Metastatic Melanoma- A Retrospective Database Analysis

    Nov 1, 2014, 00:00
  • An Economic Model to Compare the Different Empiric and First/Second Line Treatment Regimens for Suspected Methicillin-Resistant Staphylococcus Aureus Nosocomial Pneumonia

    Nov 1, 2014, 00:00
  • Optimizing Process Efficiency Through Implanting Reveal Linq Verse Reveal Xt/Dx From Three Spanish Hospital Perspective

    Nov 1, 2014, 00:00
  • Saving Money in Health Care- Cost Effectiveness of Individual Drugs (As By Nice) Or Budget Cuts (As Under Pprs)?

    Nov 1, 2014, 00:00
  • Sustainable Measurement of Response Shift in Prostate Cancer Patients- Adjusting Health Related Quality of Life with the Then-Test

    Nov 1, 2014, 00:00
  • Health Care Utilizations And Costs Of Insulin Patient-Driven Titration Versus Physician-Driven Titration- Evidence Based On A Clinical Trial Of Biphasic Insulin Aspart 30 Twice Daily In People With Type 2 Diabetes In China

    Nov 1, 2014, 00:00
  • Burden of Disease in Stage IV Non-Small Cell Lung Cancer- Comparing ALK Positive and ALK Negative Mutation Status in Egypt, Russia and the United Arab Emirates

    Nov 1, 2014, 00:00
  • Collaborative Approach in Accessing Homogeneous Medical Data in Grid-Based Environment (Enhancing Diseases Classification)

    Nov 1, 2014, 00:00
  • Costs of Absenteeism In Psoriatic and Enteropathic Arthropathies Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012

    Nov 1, 2014, 00:00
  • Breast Cancer Awareness Survey

    Nov 1, 2014, 00:00
  • Cost Effectiveness Analysis Of Mitraclip In Mitral Regurgitation For High Risk Patients

    Nov 1, 2014, 00:00
  • Pharmacy Cost Calculator for Hepatitis C Virus Patients in Turkey

    Nov 1, 2014, 00:00
  • Diagnosis And Management Of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Spain- The Ibis-C Study

    Nov 1, 2014, 00:00
  • The Impact of Long-Term Clinical Evidence on Cost-Effectiveness of Exenatide Once Weekly (Bydureon®) Versus Insulin Glargine for Patients With Type 2 Diabetes Mellitus (T2dm) From A Uk Nhs Perspective

    Nov 1, 2014, 00:00
  • Health-Related Quality of Life In Patients With Cervical Cancer in Indonesia

    Nov 1, 2014, 00:00
  • Cost Effective Analysis of Dry Powdered Inhalers Versus Metered Dose Inhalers of Salbutamol for Asthma in Rural Secondary Care Hospital of South India

    Nov 1, 2014, 00:00
  • Prioritization of Future Outcomes Research Studies in Chronic Myeloid Leukemia- Value of Information Analysis

    Nov 1, 2014, 00:00
  • Pediatrician's Perspective On Pneumococcal Conjugate Vaccines In India- An Exploratory Study

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of Amfepramone (Diethylpropion) for the Obesity Treatment In Mexico

    Nov 1, 2014, 00:00
  • Retrospective Public Health Impact of a Quadrivalent Influenza Vaccine in the United States Over the Period 2000-2014

    Nov 1, 2014, 00:00
  • A Qualitative Assessment of Doctors Perception Towards the Quality of Pharmaceutical Care Services in Khyber Pakhtunkhwa, Pakistan

    Nov 1, 2014, 00:00
  • Modelling Dependence Between Disability Status and Health Service Costs of People With Rheumatoid Arthritis in Hungary

    Nov 1, 2014, 00:00
  • Economic Burden of Hospitalized Pneumonia from a Private Health Care System Perspective in Brazil

    Nov 1, 2014, 00:00
  • Patient Access To Life-Saving Medication; Preventing Stock-Outs Due To Parallel Trade

    Nov 1, 2014, 00:00
  • MODELLING HEALTH-RELATED QUALITY OF LIFE (HRQOL) LONGITUDINALLY. A BAYESIAN MIXED BETA REGRESSION APPROACH

    Nov 1, 2014, 00:00
  • Comparative Pharmacoeconomics Studies of Treatment for Major Depressive Disorder in China

    Nov 1, 2014, 00:00
  • What Is Working Well In Louisiana For Us Employers- A Descriptive Analysis of Employers Actively Engaged In Promoting Employee Health

    Nov 1, 2014, 00:00
  • An Overview of the Biosimilar Market in the Us

    Nov 1, 2014, 00:00
  • Application Of A Model Of Decision Based On Fuzzy Logic To Pharmacoeconomics- Ranibizumab Verse Aflibercert In AMD

    Nov 1, 2014, 00:00
  • Confirmation of the Factor Structure of the Proqol-HIV Questionnaire to Assess Health-Related Quality of Life in PLWHA

    Nov 1, 2014, 00:00
  • Misuse, Abuse, and Diversion of instanyl® (Fentanyl Nasal Spray) in France

    Nov 1, 2014, 00:00
  • Impact on Hospitalization Derived from the Use of Denosumab for the Prevention of Skeletal-Related Events in Patients with Bone Metastases Secondary to Breast Cancer in Germany

    Nov 1, 2014, 00:00
  • Modeling The Impact Of A Digital Health Feedback System In Uncontrolled Hypertensive Patients

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Comparison Of Botulinum Toxin Type A Plus Best Supportive Care Versus Best Supportive Care Alone In The Treatment Of Idiopathic Overactive Bladder With Urinary Incontinence Among Patients Not Adequately Managed By Anticho ...

    Nov 1, 2014, 00:00
  • Evaluation of Potential Waste Of Growth Hormone Across Available Growth Hormone Pen Devices And An Electronic Growth Hormone Delivery Device

    Nov 1, 2014, 00:00
  • Patterns of Use of Tests to Monitor Disease Activity Among Patients With Relapsing Remitting Multiple Sclerosis in the United States and Europe

    Nov 1, 2014, 00:00
  • Analysis of Cardiac Implants Recalls in the Last Decade- An International Comparison

    Nov 1, 2014, 00:00
  • Health Related Quality of Life (Hrqol) in Multiple Myeloma Patients Treated in a Tertiary Referral Hospital

    Nov 1, 2014, 00:00
  • Indirect Costs Among Patients with Hepatitis C Virus

    Nov 1, 2014, 00:00
  • Hospital Cost of Thromboembolic Events in Breast or Prostate Cancer Patients

    Nov 1, 2014, 00:00
  • How Much the Appropriate Tobacco Price Would Be?- A Discrete Choice Experiment of General Public in Japan

    Nov 1, 2014, 00:00
  • Differential Item Functioning and the Eq-5d- Evidence From the Uk Hospital Episode Statistics

    Nov 1, 2014, 00:00
  • Risk Sharing Agreement Considerations for Pharmaceuticals in China Makret

    Nov 1, 2014, 00:00
  • Comparison in Methods Between National Institute for Health And Care Excellence (Nice) Submissions For Sodium-Glucose Co-Transporter 2 Inhibitors (Sglt-2i)

    Nov 1, 2014, 00:00
  • Drug Therapy Problems in Patients on Antihypertensives with Antidiabetic Drugs in Two Tertiary Health Institutions in Niger Delta Region, Nigeria

    Nov 1, 2014, 00:00
  • Mapping the Functional Assessment of Cancer Therapy – Breast (Fact-B) to the 5-Level Euroqol Group's 5-Dimention Questionnnaire (Eq-5d) Index in a Multi-Ethnic Asian Breast Cancer Patients

    Nov 1, 2014, 00:00
  • Treatment and Monitoring of Venous Thromboembolism (VTE) Among Hospitalized Patients in China

    Nov 1, 2014, 00:00
  • Cost-Utility Analysis (Cua) of First-Line Actinic Keratosis (Ak) Treatments in Finland

    Nov 1, 2014, 00:00
  • Re-Validation of the Self-Injection Assessment Questionnaire© (Siaqv2.0©) in Rheumatoid Arthritis Patients on Certolizumab Pegol Treatment

    Nov 1, 2014, 00:00
  • Cost and Duration Of Regulatory Process in an Observational Study in Europe and USA

    Nov 1, 2014, 00:00
  • Impact of Health Policy Changes on Trends of Pharmaceutical Market in Turkey

    Nov 1, 2014, 00:00
  • Persistence to Treatment of Chronic Hepatitis B Virus (Hbv) Infection- A Study Based on the French Ims Lifelink Treatment Dynamics (LTD) Database

    Nov 1, 2014, 00:00
  • Real World Data in Oncology- Third- and Fourth-Line Treatments Administered in Metastatic Colon-Rectal Cancer (MCRC)

    Nov 1, 2014, 00:00
  • Spontaneous Reporting of Adverse Drug Reactions in Geriatric Patients in India

    Nov 1, 2014, 00:00
  • Mcda Approach To Ranking Rare Diseases In Russia- Preliminary Results

    Nov 1, 2014, 00:00
  • Cost-Effectiveness Analysis of Screening Syphilis Among Pregnant Women

    Nov 1, 2014, 00:00
  • Prevalence and Treatment of Chronic Lymphocytic Leukaemia (Cll) In Germany- An Analysis of Sickness Funds

    Nov 1, 2014, 00:00
  • The Effects of Reforms, Price Cuts And Global Budget Implementation on Original/Generic Medicine Sales Which Have Annual Average Highest Amount Of Sales Between 2008-2013 In Turkey

    Nov 1, 2014, 00:00
  • Economic Burden of Asthma in Vietnam- An Analysis from Patients' Perspective

    Nov 1, 2014, 00:00
  • Modelling Evolving Cancer Risk During Epidemiological Transition Using Economic Data

    Nov 1, 2014, 00:00
  • Analysis of ‘Revolving Door' Patients in Opioid Dependent Patients- the Impact of Treatment Discontinuation on Relapse Rates and Health Care Costs in us Public Health Insurance Claims

    Nov 1, 2014, 00:00
  • Costs Of Treating Cardiovascular Events In Germany- A Systematic Literature Review

    Nov 1, 2014, 00:00
  • A Web Based Optimisation Model For A Portfolio Of Preventative Interventions Utilizing Multi Criteria Decision Analyses (Mcda) Framework

    Nov 1, 2014, 00:00
  • Effective Prioritisation of National Health Technology Assessments

    Nov 1, 2014, 00:00
  • Impact of Apremilast on Physical Function over 52 weeks in Patients with Active Psoriatic Arthritis

    Nov 1, 2014, 00:00
  • French Utility Elicitation in Previously Treated European Patients with Indolent Non-Hodgkin Lymphoma (INHL)

    Nov 1, 2014, 00:00
  • Factors Influencing Job Satisfaction Among Nurses of Pafos General Hospital in Cyprus

    Nov 1, 2014, 00:00
  • Study Of Costs Of The Cardiac And Diabetes Mellitus Patient In A Cardiology Hospital Of High Complexity

    Nov 1, 2014, 00:00
  • Getting To Reimbursement Faster- Combining Randomised, Pragmatic, and Observational Clinical Trial Data

    Nov 1, 2014, 00:00
  • Productivity Loss and Resource Utilization in Individuals Providing Care for Adults with Schizophrenia in the 5eu

    Nov 1, 2014, 00:00
  • Identifying Psoriasis and Psoriatic Arthritis Patients in Retrospective Databases When Diagnosis Code Is Not Available- A Validation Study Comparing Medication/Prescriber Visit Based Algorithms To Diagnosis Codes

    Nov 1, 2014, 00:00
  • Association of Changes In Body Weight With Health Care Costs Among Patients With Newly-Diagnosed Type-2 Diabetes In Sweden

    Nov 1, 2014, 00:00
  • The Efficacy and Effectiveness in HBA1C-Lowering is Dependent on Baseline Body Mass Index (BMI) for Sitagliptin but not Canagliflozin in the Treatment of Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2014, 00:00
  • Examination of the Burden of Illness of U. S. Medicare Patients Diagnosed with Chronic Obstructive Pulmonary Disease

    Nov 1, 2014, 00:00
  • The Effect of Insomnia and Insomnia Treatment Side Effects on Health Status, Work Productivity, and Health Care Resource Use

    Nov 1, 2014, 00:00
  • Burden of Disease Caused by Influenza in Germany - A Retrospective Claims Database Analysis

    Nov 1, 2014, 00:00
  • Evaluating Working Ability and Quality of Life of Patients with Multiple Sclerosis

    Nov 1, 2014, 00:00
  • Usage of Self-Monitoring of Blood Glucose (Smbg) By Diabetes Therapy Type in India

    Nov 1, 2014, 00:00
  • Budgetary Impact Analysis Of Reimbursement Varenicline In The Smoking Cessation Treatment Of Patients With Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease Or Type-2 Diabetes Mellitus- A National Health System Perspective In S ...

    Nov 1, 2014, 00:00
  • Hipos-ER (Hypoglycemia in Portugal Observational Study – Emergency Room)- Clinical Outcomes in Admitted Patients

    Nov 1, 2014, 00:00
  • Impact of Acute Bleeding on Daily Activities of Patients with Congenital Hemophilia with Inhibitors and Their Caregivers and Families- Observations from the Dosing Observational Study in Hemophilia (DOSE)

    Sep 1, 2014, 00:00
  • Impact of Mental Health Comorbidities on Health Care Utilization and Expenditure in a Large US Managed Care Adult Population with ADHD

    Sep 1, 2014, 00:00
  • Table of Contents

    Sep 1, 2014, 00:00
  • Copyright/Subscription

    Sep 1, 2014, 00:00
  • Transitions between Care Settings in Dementia- Are They Relevant in Economic Terms?

    Sep 1, 2014, 00:00
  • It’s Good to Have a Choice; Now Let’s Get More Data- Response to Armstrong et al.’s “Response to Lai et al., Development of a Symptom Index for Patients with Primary Brain Tumors”

    Sep 1, 2014, 00:00
  • Instructions for Authors

    Sep 1, 2014, 00:00
  • The Nocturia Impact Diary- A Self-Reported Impact Measure to Complement the Voiding Diary

    Sep 1, 2014, 00:00
  • Mapping between the Roland Morris Questionnaire and Generic Preference-Based Measures

    Sep 1, 2014, 00:00
  • A Patient-Level Calibration Framework for Evaluating Surveillance Strategies- A Case Study of Mammographic Follow-Up After Early Breast Cancer

    Sep 1, 2014, 00:00
  • Analyzing Overall Survival in Randomized Controlled Trials with Crossover and Implications for Economic Evaluation

    Sep 1, 2014, 00:00
  • Can Value-Based Insurance Impose Societal Costs?

    Sep 1, 2014, 00:00
  • Pharmaceutical Portfolio Management- Global Disease Burden and Corporate Performance Metrics

    Sep 1, 2014, 00:00
  • Validation of the IMS CORE Diabetes Model

    Sep 1, 2014, 00:00
  • Editorial Board

    Sep 1, 2014, 00:00
  • Response to Lai et al., “Development of a Symptom Index for Patients with Primary Brain Tumors”

    Sep 1, 2014, 00:00
  • Cancer Chemotherapy Treatment Patterns and Febrile Neutropenia in the US Veterans Health Administration

    Sep 1, 2014, 00:00
  • Dynamic Medication Adherence Modeling in Primary Prevention of Cardiovascular Disease- A Markov Microsimulation Methods Application

    Sep 1, 2014, 00:00
  • Table of Contents

    Jul 1, 2014, 00:00
  • NICE’s Selective Application of Differential Discounting- Ambiguous, Inconsistent, and Unjustified

    Jul 1, 2014, 00:00
  • Copyright/Subscription

    Jul 1, 2014, 00:00
  • A Framework to Evaluate the Cost-Effectiveness of the NADiA ProsVue Slope to Guide Adjuvant Radiotherapy among Men with High-Risk Characteristics Following Prostatectomy for Prostate Cancer

    Jul 1, 2014, 00:00
  • PRO Data Collection in Clinical Trials Using Mixed Modes- Report of the ISPOR PRO Mixed Modes Good Research Practices Task Force

    Jul 1, 2014, 00:00
  • Chinese Time Trade-Off Values for EQ-5D Health States

    Jul 1, 2014, 00:00
  • Comparison of Contemporaneous EQ-5D and SF-6D Responses Using Scoring Algorithms Derived from Similar Valuation Exercises

    Jul 1, 2014, 00:00
  • Two Approaches to Incorporate Clinical Data Uncertainty into Multiple Criteria Decision Analysis for Benefit-Risk Assessment of Medicinal Products

    Jul 1, 2014, 00:00
  • Time Is Money, But How Much? The Monetary Value of Response Time for Thai Ambulance Emergency Services

    Jul 1, 2014, 00:00
  • Review of the Task Force Report on PRO Data Collection in Clinical Trials Using Mixed Modes

    Jul 1, 2014, 00:00
  • Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease- Cross-Model Comparison of Hypothetical Treatment Scenarios

    Jul 1, 2014, 00:00
  • Treating to Target with Etanercept in Rheumatoid Arthritis- Cost-Effectiveness of Dose Reductions When Remission Is Achieved

    Jul 1, 2014, 00:00
  • Improving the Contribution of Regulatory Assessment Reports to Health Technology Assessments—A Collaboration between the European Medicines Agency and the European network for Health Technology Assessment

    Jul 1, 2014, 00:00
  • Cognitive Overload? An Exploration of the Potential Impact of Cognitive Functioning in Discrete Choice Experiments with Older People in Health Care

    Jul 1, 2014, 00:00
  • Should I Stay or Should I Go Home? A Latent Class Analysis of a Discrete Choice Experiment on Hospital-At-Home

    Jul 1, 2014, 00:00
  • An Updated Method for Risk Adjustment in Outcomes Research

    Jul 1, 2014, 00:00
  • A Comparison of National Guidelines for Network Meta-Analysis

    Jul 1, 2014, 00:00
  • The Effects of Total Knee Arthroplasty on Physical Functioning and Health among the Under Age 65 Population

    Jul 1, 2014, 00:00
  • An Economic Evaluation of Salt Reduction Policies to Reduce Coronary Heart Disease in England- A Policy Modeling Study

    Jul 1, 2014, 00:00
  • The Role of Economic Evaluation in Meeting IOM’s Recommendations on Delivering High-Quality Cancer Care

    Jul 1, 2014, 00:00
  • Editorial Board

    Jul 1, 2014, 00:00
  • A Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension versus Standard Pump Therapy for Hypoglycemic Unaware Patients with Type 1 Diabetes

    Jul 1, 2014, 00:00
  • The Effect of Presenting Information about Invasive Follow-Up Testing on Individuals’ Noninvasive Colorectal Cancer Screening Participation Decision- Results from a Discrete Choice Experiment

    Jul 1, 2014, 00:00
  • Instructions for Authors

    Jul 1, 2014, 00:00
  • Physician Social Networks and Variation in Rates of Complications After Radical Prostatectomy

    Jul 1, 2014, 00:00
  • In the paper “A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making- An ISPOR-AMCP-NPC Good Practice Task Force Report” published in Value in Health, Volume 17 (March/April 20 ...

    Jun 1, 2014, 00:00
  • Estimation of Potential Gain in Quality of Life from Early Detection of Cervical Cancer

    Jun 1, 2014, 00:00
  • Long-Term Air Humidification Therapy Is Cost-Effective for Patients with Moderate or Severe Chronic Obstructive Pulmonary Disease or Bronchiectasis

    Jun 1, 2014, 00:00
  • Patient-Centeredness in the Design of Clinical Trials

    Jun 1, 2014, 00:00
  • Cost-Effectiveness of a Computerized Provider Order Entry System in Improving Medication Safety Ambulatory Care

    Jun 1, 2014, 00:00
  • Multicriteria Decision Analysis in the Reimbursement of New Medical Technologies- Real-World Experiences from Hungary

    Jun 1, 2014, 00:00
  • Is the UK NICE “Reference Case” Influencing the Practice of Pediatric Quality-Adjusted Life-Year Measurement within Economic Evaluations?

    Jun 1, 2014, 00:00
  • Instructions for Authors

    Jun 1, 2014, 00:00
  • Comparative Cost Analysis of Clinical Reminder for HIV Testing at the Veterans Affairs Healthcare System

    Jun 1, 2014, 00:00
  • A Review of FDA Warning Letters and Notices of Violation Issued for Patient-Reported Outcomes Promotional Claims between 2006 and 2012

    Jun 1, 2014, 00:00
  • Sharing Risk between Payer and Provider by Leasing Health Technologies- An Affordable and Effective Reimbursement Strategy for Innovative Technologies?

    Jun 1, 2014, 00:00
  • Bazedoxifene versus Oral Bisphosphonates for the Prevention of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis at Higher Risk of Fracture- A Network Meta-Analysis

    Jun 1, 2014, 00:00
  • Searching for Indirect Evidence and Extending the Network of Studies for Network Meta-Analysis- Case Study in Venous Thromboembolic Events Prevention Following Elective Total Knee Replacement Surgery

    Jun 1, 2014, 00:00
  • A Retrospective, Observational Study of Patient Outcomes for Critically Ill Patients Receiving Parenteral Nutrition

    Jun 1, 2014, 00:00
  • Review of Utility Values for Economic Modeling in Type 2 Diabetes

    Jun 1, 2014, 00:00
  • A Study of the Relationship between Health and Subjective Well-Being in Parkinson’s Disease Patients

    Jun 1, 2014, 00:00
  • Discrete Choice Experiment to Estimate Breast Cancer Patients’ Preferences and Willingness to Pay for Prophylactic Granulocyte Colony-Stimulating Factors

    Jun 1, 2014, 00:00
  • Copyright/Subscription

    Jun 1, 2014, 00:00
  • Patient Preferences for Treatment of Low Back Pain—A Discrete Choice Experiment

    Jun 1, 2014, 00:00
  • A Comparison of Hong Kong and United Kingdom SF-6D Health States Valuations Using a Nonparametric Bayesian Method

    Jun 1, 2014, 00:00
  • Construct Validity of the Swedish Version of the Revised Piper Fatigue Scale in an Oncology Sample—A Rasch Analysis

    Jun 1, 2014, 00:00
  • Development of a Scale to Assess Performance Following Primary Total Knee Arthroplasty

    Jun 1, 2014, 00:00
  • A Program of Methodological Research to Arrive at the New International EQ-5D-5L Valuation Protocol

    Jun 1, 2014, 00:00
  • Editorial Board

    Jun 1, 2014, 00:00
  • Cost-Effectiveness of Second-Generation Antipsychotics for the Treatment of Schizophrenia

    Jun 1, 2014, 00:00
  • Table of Contents

    Jun 1, 2014, 00:00
  • Questioning Patient Subgroups for Benefit Assessment- Challenging the German Gemeinsamer Bundesausschuss Approach

    Jun 1, 2014, 00:00
  • Medical Device Reimbursement Coverage and Pricing Rules in Korea- Current Practice and Issues with Access to Innovation

    Jun 1, 2014, 00:00
  • Modeling a Preference-Based Index for Two Condition-Specific Measures (Asthma and Overactive Bladder) Using a Nonparametric Bayesian Method

    Jun 1, 2014, 00:00
  • The Impact of Differences between Patient and General Population EQ-5D-3L Values on the Mean Tariff Scores of Different Patient Groups

    Jun 1, 2014, 00:00
  • Prevalence Of Prescription Medication Use Not Captured By Prescription Claims Databases

    May 1, 2014, 00:00
  • Estimating Long-Term Functional Impairments Of Rheumatoid Arthritis- Integration Of Nationwide Survival With Health Assessment From Clinical Cohort

    May 1, 2014, 00:00
  • Eight Years Experience With Availability And Uptake Of Orphan Drugs With Or Without Prior Eu Orphan Designation In Slovakia

    May 1, 2014, 00:00
  • Blood Pressure Testing At Community Pharmacies Promote Better Hypertension Management

    May 1, 2014, 00:00
  • The Use Of Pillbox And Time In Therapeutic Range Among New Users Of Warfarin- A Propective Cohort Study

    May 1, 2014, 00:00
  • The Affordable Care Act And Pharmacy Benefit Managers- Health Care Exchanges And Projected Outcomes

    May 1, 2014, 00:00
  • Comparison Of Annual Cost And Resource Utilization For Heart Failure Patients In South Korea- Between 2009 And 2011

    May 1, 2014, 00:00
  • Value Of A Zero-Copay Drug Program- Implication For Employee Wellness Programs

    May 1, 2014, 00:00
  • Utilizing Nordic Registries To Support Health Economics Research In Rheumatic Diseases

    May 1, 2014, 00:00
  • Developing a behavioral framework for cost-related medication non-compliance among older diabetes patients

    May 1, 2014, 00:00
  • Clinical Outcomes and Budget Impact of Cobas® Egfr Mutation Test Versus Sanger Sequencing in the Treatment of Locally Advanced or Metastatic Nsclc- A United States Payer Perspective

    May 1, 2014, 00:00
  • Survival crossover adjustment and cost effectiveness analysis- An empirical and methodological review with application

    May 1, 2014, 00:00
  • Simulation and Comparison of Progression-Free Survival (Pfs) Among Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Receiving Sequential Therapy

    May 1, 2014, 00:00
  • Treatment and Survival Patterns Among Elderly Medicare Beneficiaries with Colorectal Cancer- A Comparative Analysis Between a Rural State Cancer Registry and National Data

    May 1, 2014, 00:00
  • The Effect Of Medicare Part D On Medication Prescribing Patterns And Drug Utilization- The Case Of Non-Benzodiazepine Sedative Hypnotics

    May 1, 2014, 00:00
  • Estimation Of Change In Prescription Drug Expenditures On The Reference Pricing System In South Korea

    May 1, 2014, 00:00
  • Patient-Reported Outcome (Pro) Claims In Products Indicated For The Treatment Of Rare Diseases And Approved By The European Medicines Agency (Ema)

    May 1, 2014, 00:00
  • Life years lost and lifetime health care expenditures associated with diabetes in the United States

    May 1, 2014, 00:00
  • Cost Effectiveness Analysis Of Mri Guided Ablation Based On The Decaaf Trial

    May 1, 2014, 00:00
  • A Mixed Treatment Comparison (Mtc) To Compare The Efficacy Of Botulinum Toxin Type A Treatments For Cervical Dystonia

    May 1, 2014, 00:00
  • Economic Impact Of Vaccination With 10-Valent Versus 13-Valent Pneumococcal Conjugated Vaccines In Colombia

    May 1, 2014, 00:00
  • Pneumococcal Vaccine Targeting Strategy For The Older Adults- Customized Risk Profiling

    May 1, 2014, 00:00
  • Recent trends in post-traumatic stress disorder-related hospitalizations in the united states

    May 1, 2014, 00:00
  • Health Care Cost and Utilization Among Patients Treated with Stivarga

    May 1, 2014, 00:00
  • what happens when personalized medicine guidelines don’t agree? A systematic review of clinical guidelines for thiopurine methyltransferase testing for dose selection of thiopurines

    May 1, 2014, 00:00
  • Validation Of The Huntington Clinical Self-Reported Instrument (H-Csri) In United States

    May 1, 2014, 00:00
  • Pharmacoeconomic Analysis Of Dabigatran In Patients With Atrial Fibrillation- Comparison With Rivaroxaban Or Apixaban

    May 1, 2014, 00:00
  • Health Care Utilization And Costs Among Privately Insured Children With Orofacial Clefts

    May 1, 2014, 00:00
  • Opportunities For The Future Of United States Medical Device Surveillan An Analysis Of The Joint Replacement Registry (Jrr) Landscape In The United States

    May 1, 2014, 00:00
  • A Probabilistic Budget Impact Analysis Of Cystic Fibrosis Therapy On Health Plan Pharmacy Budgets

    May 1, 2014, 00:00
  • Budget Impact Analysis Of Tocilizumab In Rheumatoid Arthritis (Ra) In Colombia

    May 1, 2014, 00:00
  • Utilization, Costs And Reimbursement Of Inpatient Treatment Of Acute Bacterial Skin And Skin Structure Infections Among The Medicare Fee-For-Service Population

    May 1, 2014, 00:00
  • Improved bootstrap point and confidence interval estimation of the incremental cost-effectiveness ratio (ICER)

    May 1, 2014, 00:00
  • Systematic Literature Review Of Compliance And Persistence Programs In Inflammation And Immunology

    May 1, 2014, 00:00
  • Impact of linaclotide on work productivity and daily activity impairment among adults with irritable bowel syndrome with constipation- results from a 26-week phase 3 trial

    May 1, 2014, 00:00
  • Cost Consequence Analysis Of Apixaban Versus Warfarin In Patients With Atrial Fibrillation In The Mexican Public Health Sector

    May 1, 2014, 00:00
  • Evaluation Analysis Comparing Tiotropium With Salmeterol Or Ipratropium In Chronic Obstructive Pulmonary Disease In Taiwan

    May 1, 2014, 00:00
  • Perceived Benefits And Barriers Of Payer-Manufacturer Post-Marketing Outcomes Study Collaborations

    May 1, 2014, 00:00
  • What are the roles of health economic models in product development?

    May 1, 2014, 00:00
  • Increased In Acute Health Care Use Among People Living With Human Immunodeficiency Virus (Hiv) And Co-Morbid Depression In Ontario- A Longitudinal Study

    May 1, 2014, 00:00
  • Delayed Treatment Modifications For Patients With Type 2 Diabetes Mellitus (T2dm) With Very Poor Glycemic Control

    May 1, 2014, 00:00
  • Cost Of Intraveneous Patient-Controlled Analgesia (Iv Pca) Equipment And Opioid Medication For Orthopedic And Abdominal Surgeries In United States Hospitals

    May 1, 2014, 00:00
  • Clinical outcomes among elderly medicare beneficiaries having chronic illness with complexity- A medicare advantage population study

    May 1, 2014, 00:00
  • Real-World Utilization Of Certolizumab Pegol (Czp) For The Treatment Of Rheumatoid Arthritis (Ra) In The United Kingdom

    May 1, 2014, 00:00
  • The Association of Chemotherapy Versus Hormonal Therapy and Health Outcomes Among Patients with Hormone Receptor-Positive, Her2-Negative Metastatic Breast Cancer- Experience From the Patient Perspective

    May 1, 2014, 00:00
  • Expected Cost-Utility Of Quadrivalent Influenza Vaccine Under A Universal Influenza Immunization Program In Ontario, Canada

    May 1, 2014, 00:00
  • Applying Data Analytics to Value-Based Cancer Care- Effects and Cost of Hospital Reencounters Following Cancer Surgery

    May 1, 2014, 00:00
  • Automatic development of clinical prediction models with genetic programming- A case study in cardiovascular disease

    May 1, 2014, 00:00
  • A Retrospective, Cross Sectional Study On The Real-World Values Of Cardiovascular Risk Factors Using A Health Care Database In Japan

    May 1, 2014, 00:00
  • Somatropin dose analysis for treatment of hypopituitarism in public Brazilian health system (SUS)

    May 1, 2014, 00:00
  • Heterogeneity of health care costs among medicare advantage patients with type 1 diabetes

    May 1, 2014, 00:00
  • Conceputalizing A Model To Assess The Impact Of International Reference Pricing Reforms

    May 1, 2014, 00:00
  • Adherence barriers to ace-is and arbs among non-adherent hypertensive patients with diabetes enrolled in a medicare advantage plan

    May 1, 2014, 00:00
  • The Humanistic And Economic Burden Of Restless Legs Syndrome

    May 1, 2014, 00:00
  • Rituximab As First Choice For Patients With Refractory Rheumatoid Arthritis- A Systematic Review And Cost-Effectiveness Analysis

    May 1, 2014, 00:00
  • From private sites to big data without compromising privacy- A case of neuroimaging data classification

    May 1, 2014, 00:00
  • Risk heterogeneity in clinical trials- An evaluation of 25 large clinical trials using individual patient data

    May 1, 2014, 00:00
  • Literature Review Of Functional, Educational, And Motivational Adherence Interventions

    May 1, 2014, 00:00
  • Quality of life among adults with autism spectrum disorders

    May 1, 2014, 00:00
  • Identifying and characterizing trajectories of qol in persons with advanced cancer- Important contributors to decreasing QOL in people with cancer

    May 1, 2014, 00:00
  • Long-Acting Muscarinic Antagonists (Lama) In Chronic Obstructive Pulmonary Disease (Copd)- A Rare Events Meta Analysis Of Clinically Relevant Adverse Events

    May 1, 2014, 00:00
  • Academy Of Managed Care Pharmacy (Amcp) Dossiers- Use In Health Care Decision Making

    May 1, 2014, 00:00
  • Biosimilars- Friends Or Foe For Payers, Physicians And Manufacturers?

    May 1, 2014, 00:00
  • Cost Effectiveness Analysis Of Respiratory Syncytial Virus Infection Prophylaxis In Children With Congenital Heart Disease

    May 1, 2014, 00:00
  • Progress In Personalized Medicine Is Slower Than Some Had Expected, Partly Because Of The Science And Partly Because Of Insufficient Economic Incentives, Particularly For Investing In Molecular Diagnostics (MDX)

    May 1, 2014, 00:00
  • Non-Adherence is Associated with Poorer Health Outcomes Among Women Currently Treated for Breast Cancer with Oral Endocrine Therapy

    May 1, 2014, 00:00
  • Evaluation Long-Term Effects Of Treatment And Response On Health Related Quality Of Life Among Patients With Chronic Hepatitis C

    May 1, 2014, 00:00
  • «
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110 (current)
  • »